Harnessing Epigenetics And Nanobiotechnology For Precision Medicine: Revolutionizing Stem Cell Therapy.
Keywords:
Epigenetics, Nanobiotechnology, Stem Cell Therapy, Precision Medicine, Ethical Considerations, Public Perception, Gene Editing, Personalized MedicineAbstract
Purpose:The purpose of this study is to explore the integration of epigenetics and nanobiotechnology in advancing precision medicine, with a particular focus on their application in stem cell therapy. The study aims to assess the awareness, perceptions, and experiences of individuals regarding the potential of these technologies in revolutionizing stem cell-based treatments.
Aim:The aim of this research is to evaluate the level of familiarity with epigenetics and nanobiotechnology, measure the perceived effectiveness of these technologies in stem cell applications, and identify the ethical concerns and barriers to their widespread implementation.
Approach:A mixed-methods approach was employed to collect both quantitative and qualitative data. A survey consisting of Likert-scale and open-ended questions was administered electronically to 140 participants from diverse backgrounds, including researchers, healthcare professionals, and the general public. The survey assessed demographic information, familiarity with epigenetics and nanobiotechnology, their potential applications in stem cell therapy, ethical concerns, and the future outlook on these technologies.
Methods:The data was collected using a structured questionnaire that included sections on demographic details, awareness of epigenetics and nanobiotechnology, potential applications in stem cell therapies, ethical considerations, and future outlook. The data was analyzed using descriptive statistics for the quantitative data and thematic analysis for the qualitative data to identify key themes and patterns in participants’ responses.
Results:The results revealed that a significant proportion of respondents were familiar with epigenetics and nanobiotechnology, and most were optimistic about their potential in advancing stem cell therapies. Ethical concerns regarding gene editing and the accessibility of treatments were prominent, while public perception and regulatory challenges were identified as major barriers to implementation.
Findings:The findings indicate strong support for the use of epigenetics and nanobiotechnology in precision medicine, with particular emphasis on stem cell differentiation and personalized medicine. However, the ethical implications and potential risks of gene editing and nanobiotechnology must be carefully managed to ensure responsible application.
Theoretical and Practical Implications: The study contributes to the theoretical understanding of how epigenetics and nanobiotechnology can reshape stem cell therapies by providing insight into public perceptions, ethical concerns, and the potential for personalized treatments. Practically, the findings highlight the need for better regulatory frameworks and public education to facilitate the acceptance and responsible use of these technologies.
Originality/Value:This study is one of the first to comprehensively evaluate the perceptions and experiences of individuals regarding the integration of epigenetics and nanobiotechnology in stem cell therapy. The research provides valuable insights into the challenges and opportunities these technologies present for the future of precision medicine
Downloads
References
Hussen, B.M., et al., Revolutionizing medicine: recent developments and future prospects in stem-cell therapy. International Journal of Surgery, 2024. 110(12): p. 8002-8024.
Anurogo, D., The Art of Nanoimmunobiotechnomedicine in Stem Cells and Gene Editing. Journal ISSN, 2023. 2766: p. 2276.
Malik, R. and I. Ullah, Stem Cell Therapy: Revolutionizing Regenerative Medicine. The Research of Medical Science Review, 2023. 1(02): p. 20-28.
Taeb, S., et al., Revolutionizing Cancer Treatment: Harnessing the Power of Mesenchymal Stem Cells for Precise Targeted Therapy in the Tumor Microenvironment. Current Topics in Medicinal Chemistry, 2025. 25(3): p. 243-262.
El-Tanani, M., et al., Deciphering the role of cancer stem cells: Drivers of tumor evolution, therapeutic resistance, and precision medicine strategies. Cancers, 2025. 17(3): p. 382.
Thamarai, P., et al., Current advancements in nanotechnology for stem cells. International Journal of Surgery, 2024. 110(12): p. 7456-7476.
Vizirianakis, I.S., Handbook of personalized medicine: advances in nanotechnology, drug delivery, and therapy. 2014: CRC Press.
Kumar, P., Advances in developing novel therapeutics, strategies, approaches, and use of emerging techniques, in Protein Misfolding in Neurodegenerative Diseases. 2025, Elsevier. p. 291-318.
Ghosh, A., et al., Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer. Molecular Pharmaceutics, 2023. 20(12): p. 5981-6009.
Alzate-Correa, D., et al., Nanotechnology-driven cell-based therapies in regenerative medicine. The AAPS journal, 2022. 24(2): p. 43.
Mohammadi, A.T., et al., Exploring Boundless Horizons: Medicine and Pharmacy. 2024: Nobel Sciences.
Rathore, R., A. Kumar, and A. Thakur, Synthetic DNA and Programmable Genomes in Nanobiology, in Advancements in Nanobiology. 2025, CRC Press. p. 280-302.
Odah, M., From the Double Helix to Precision Genomics: A Comprehensive Review of DNA and Its Transformative Role in Biomedical Sciences. 2024.
Fagbemi, O.A., et al., Epigenetic therapies in cancer treatment: Opportunities and challenges. 2024.
Eksi, O.B., et al., Nanodelivery in Gene Therapy: Unlocking the Potential for Precision Medicine, in Handbook of Cancer and Immunology. 2024, Springer. p. 1-40.
Kumar, R., et al., Deciphering the frontiers of stem cell research in regenerative medicine. Chemical Biology Letters, 2024. 11(4): p. 673-673.
Dhoundiyal, S. and M.A. Alam, Advancements in Biotechnology and Stem Cell Therapies for Breast Cancer Patients. Current Stem Cell Research & Therapy, 2024. 19(8): p. 1072-1083.
Obisi, J.N., et al., Unveiling the future of cancer stem cell therapy: a narrative exploration of emerging innovations. Discover Oncology, 2025. 16(1): p. 373.
EGE, H. and O. EKİCİ, Regenerative Medicine: Harnessing Stem Cells for Sustainable Healing. New Generation Technologies and Sustainability in Health: Current Studies: p. 28.
Qureshi, M.A., et al., Revolutionizing Breast Cancer Care: Cutting-Edge Breakthroughs and Future Frontiers in Precision Medicine, in Breast Cancer Treatment: An Interdisciplinary Approach. 2024, Springer. p. 115-141.
Addissouky, T.A., Next Generation of Colorectal Cancer Management: Integrating Omics, Targeted Therapies, and Smart Technologies. Avicenna Journal of Medical Biochemistry, 2024. 12(2): p. 131-143.
Hamdy, N.M., et al., Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine. Current Medical Research and Opinion, 2024. 40(11): p. 1943-1961.
Ravichandran, S. and G. Verma, Advanced biotechnology-based therapeutics, in Translational Biotechnology. 2021, Elsevier. p. 53-77.
Mir, G.J., et al., Cancer Stem Cells as Promising Nanotherapeutic Targets, in Personalized and Precision Nanomedicine for Cancer Treatment. 2024, Springer. p. 27-68.
Saliev, T. and P.B. Singh, From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications. Cells, 2024. 13(24): p. 2052.
Yang, M., et al., Harnessing nanotechnology: emerging strategies for multiple myeloma therapy. Biomolecules, 2024. 14(1): p. 83.
Tinger, L., Development of an integrated platform for personalized cancer treatment: diagnostic and therapeutic solutions based on biomarkers and nanotechnology. 2024.
Ajekiigbe, V.O., et al., Innovative approaches to treatment of eye diseases: advances in stem cell therapy use in ophthalmology. International Ophthalmology, 2025. 45(1): p. 113.
Umer, A., et al., Engineered Nano–Bio Interfaces for Stem Cell Therapy. Precision Chemistry, 2023. 1(6): p. 341-356.
Mahmood, M., et al., Revolutionizing personalized cancer treatment: the synergy of next-generation sequencing and CRISPR/Cas9. Personalized Medicine, 2024. 21(3): p. 175-190...
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
